Stock Institutional Ownership and Shareholders

SecurityADVM / Adverum Biotechnologies, Inc. (05337G107)
President and CEOSalzman Amber
Institutional Owners2
Outstanding Shares43,381,000 (as of 2017-09-30)
Related AAVL / Avalanche Biotechnologies, Inc.

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include Group One Trading, L.p., and Simplex Trading, Llc.

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
Prev Value (x$1000) Current Value (x$1000) Change
2017-10-25 13F-HR SIMPLEX TRADING, LLC Put 10 10 0.00 0 0
2017-11-15 13F-HR GROUP ONE TRADING, L.P. Put 5,200 5,200 0.00 13 19 46.15
CUSIP: 05337G107